PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 4.89

Change

-0.29 (-5.60)%

Market Cap

N/A

Volume

0.66M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.47 (+8.58%)

USD 8.14B
QLD ProShares Ultra QQQ

+3.03 (+3.01%)

USD 5.50B
SSO ProShares Ultra S&P500

+1.19 (+1.36%)

USD 4.33B
FNGU MicroSectors FANG+ Index 3X Le..

N/A

USD 4.29B
UPRO ProShares UltraPro S&P500

+1.58 (+2.03%)

USD 2.91B
TECL Direxion Daily Technology Bull..

+4.41 (+6.35%)

USD 1.95B
YINN Direxion Daily FTSE China Bull..

-0.90 (-2.35%)

USD 1.19B
USD ProShares Ultra Semiconductors

+4.45 (+9.04%)

USD 0.61B
UDOW ProShares UltraPro Dow30

-1.63 (-1.91%)

USD 0.56B
LABU Direxion Daily S&P Biotech Bul..

-3.76 (-7.24%)

USD 0.53B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -31.13% 4% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -31.13% 4% F 5% F
Trailing 12 Months  
Capital Gain -29.23% 16% F 10% F
Dividend Return 0.74% 56% F 14% F
Total Return -28.49% 15% F 10% F
Trailing 5 Years  
Capital Gain -66.69% 6% D- 5% F
Dividend Return 1.91% 11% F 4% F
Total Return -64.78% 6% D- 4% F
Average Annual (5 Year Horizon)  
Capital Gain 51.23% 90% A- 95% A
Dividend Return 51.85% 88% B+ 95% A
Total Return 0.63% 42% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 392.96% 7% C- 3% F
Risk Adjusted Return 13.20% 28% F 32% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.